Contents

Current Pharmaceutical Biotechnology, Volume 7 - Number 5

Editorial [Hot Topic: New Perspectives in the Treatment of Hematological Malignancies (Guest Editor: Masahiro Kizaki)]

, 7(5): 313

Masahiro Kizaki


DOI: 10.2174/138920106778521550




DNA Hypermethylation of Myeloid Cells, A Novel Therapeutic Target in MDS and AML

, 7(5): 315 - 321

Claudia I. Muller, Bjorn Ruter, H. Phillip Koeffler and Michael Lubbert


DOI: 10.2174/138920106778521523




Induction of Apoptosis via the Modulation of Reactive Oxygen Species (ROS) Production in the Treatment of Myeloid Leukemia

, 7(5): 323 - 329

Masahiro Kizaki, Mingji Xian, Morihiko Sagawa and Yasuo Ikeda


DOI: 10.2174/138920106778521541




Developing Target Therapy Against Oncogenic Tyrosine Kinase in Myeloid Maliganacies

, 7(5): 331 - 337

Tomoki Naoe


DOI: 10.2174/138920106778521514




Immunomodulatory Drugs (IMiDs™): A New Treatment Option for Myelodysplastic Syndromes

, 7(5): 339 - 342

Vishakha Kale and Alan F. List


DOI: 10.2174/138920106778521587




Monoclonal Antibodies for the Treatment of Acute Myeloid Leukemia

, 7(5): 343 - 369

Syed A. Abutalib and Martin S. Tallman


DOI: 10.2174/138920106778521578




New Tyrosine Kinase Inhibitors in the Treatment of Chronic Myeloid Leukemia

, 7(5): 371 - 379

Shinya Kimura, Eishi Ashihara and Taira Maekawa


DOI: 10.2174/138920106778521532




Recent Advances in the Treatment of Multiple Myeloma

, 7(5): 381 - 393

Hiroshi Yasui, Teru Hideshima, Paul G. Richardson and Kenneth C. Anderson


DOI: 10.2174/138920106778521569




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science